Le Lézard
Classified in: Ebola virus
Subject: SVY

Global Ebola Partnering 2010 to 2017



LONDON, Nov. 22, 2017 /PRNewswire/ --

Download the full report: https://www.reportbuyer.com/product/3605724

? Trends in partnering deals
? Top deals by value
? Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered ? contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2010 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2010 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Download the full report: https://www.reportbuyer.com/product/3605724

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer


These press releases may also interest you

19 jan 2018
In recognition of their work towards the prevention of infectious diseases, including the deadly H7N9 Bird Flu virus, a team led by Professor Li Lanjuan have been presented with the Grand Prize of China's National Science and Technology Progress...

18 jan 2018
This report analyzes the worldwide markets for Tampons in terms of retail value sales in US$ Thousand.Read the full report: https://www.reportlinker.com/p090574 The report provides separate comprehensive analytics for the US, Canada, Japan, Europe,...

18 jan 2018
The "Tampons - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World....

18 jan 2018
Aethlon Medical, Inc. , a therapeutic technology company focused on unmet needs in global health and biodefense, today announced that the United States Patent and Trademark Office has allowed U.S. Patent Application Number 14/490,418 ("the '418...

17 jan 2018
SKF's Nomination Committee proposes Hans Stråberg as new Chairman of the Board of AB SKF. Hans Stråberg is Chairman of the Board of Atlas Copco AB, Roxtec AB, CTEK AB, Nikkarit Holding AB; Vice Chairman of the Board of Stora Enso Oyj, Orchid...

16 jan 2018
? CTV's acclaimed Canadian drama series CARDINAL leads Bell Media productions with 12 nominations ?? CraveTV Original Series LETTERKENNY receives nine; the final seasons of Space's ORPHAN BLACK and CTV's 19-2 each receive six ?? Discovery Channel...




News published on 22 november 2017 at 15:53 and distributed by: